R&D Trends in the Asia-Pacific

Sep 24, 2018

While pharmaceutical research continues to grow steadily, with a forecast compound annual growth rate of over 3% for 2015–2020, the untold story may be the growth in outsourcing to CROs. Frost & Sullivan forecast CRO market penetration will rise from 28.9% in 2015 ($31.8 billion revenue) to 42.6% in 2020 ($56.4 billion revenue). Dr John Moller of Novotech CRO concludes with an examination of the regional CRO alliance model. ...

Read More

Subject Recruitment and Retention for Clinical Trial Success

Sep 24, 2018

Professor Christene Leiper of Onorach identifies why it is crucial from the outset when planning a clinical trial to have an adequate sample size. Recruiting to target will mean that the trial will have a high probability of completing within timelines. Low rates of recruitment and retention have a number of negative implications, such as longer durations of the clinical trial, which may lower staff and participant morale; a costlier clinical trial, since extra resources may need to be dedicated to the recruitment effort; and less statistical power for both the study and the validity of the results. ...

Read More

The Second Age of Digital and the Rise of the Multichannel Rep

Sep 24, 2018

As digital continues to permeate the life sciences industry, it is having a transformative impact on commercial organisations’ ability to engage their many stakeholders, from healthcare professionals (HCPs) to patients. It has not only helped companies move beyond face-to-face interactions to increase reach through multiple touch points, but has also driven coordination and orchestration among field, sales, medical, and external teams for much greater efficiency. Chris Wade of Veeva looks at why independents overtake relationship-seekers. ...

Read More

Breaking Down Barriers to Digital Advancement in Life Sciences R&D

Sep 24, 2018

Life sciences organisations must be clear what they are aiming for if they are to fully exploit the opportunities offered by digital technologies, yet disconnected strategies and overlapping projects are preventing progress. Dr Nicholas Lakin of Kinapse provides practical recommendations for a more holistic approach to transformation and delivering tangible benefits where these are needed most. He concludes that lowering barriers enables better outcomes. ...

Read More

Serialisation and Data Connectivity – the New Wrinkle in your Supply Chain

Sep 24, 2018

Ben Jones of PCI Pharma Services explores the attractiveness of the US drug market for selling pharmaceutical therapies. With a population of more than 330 million people, it is valued at $358 billion annually and represents approximately 44% of the total global pharmaceutical market. Pharmaceutical companies operating in the United States are now expected to have taken initial steps in securing their supply chain, complying with the Drug Safety and Supply Chain Act (DSCSA) effective November of 2017. ...

Read More